Dayal Sujata Tyagi 4
4 · Emergent BioSolutions Inc. · Filed Nov 10, 2025
Insider Transaction Report
Form 4
Dayal Sujata Tyagi
Director
Transactions
- Sale
Common Stock
2025-11-07$10.00/sh−8,552$85,520→ 88,980 total
Footnotes (2)
- [F1]All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on August 8, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- [F2]All shares sold at an exact price of $10.00.